Farmas USA

Chapeau ese post y el año que has hecho, macho.
Ya te lo dije, lo flipo y me quito el sombrero. Los chicharros son una disciplina sobre la que mi intuicion es completamente nula y por eso me asombra el doble.

:)

Pero eso de los dos meses no lo habían quitado?

Creo que para usa es 1 año

Algo de eso ya lo hemos hablado por aqui, si ... USA es un año. Un sin sentido. Respeta tu eso, nah.

Que yo sepa, a día de hoy,no.
Para USA es un año, pero he leído por hay varias veces, que suele ser un coladero en hacienda si tienes muchos movimientos pasados esos 2 meses; Claro, que... también te pueden enganchar.

To the Stockholders of Melinta Therapeutics, Inc.:

You are cordially invited to attend a special meeting of the stockholders, or the Special Meeting, of Melinta Therapeutics, Inc., a Delaware corporation, which we refer to as Melinta or the Company, which will be held at 10:00 a.m., local time, on December 27, 2017, at the offices of Willkie Farr & Gallagher LLP located at 787 7^th Avenue, New York , NY 10019,

Under the terms of the Medicines purchase agreement, the purchase price consists of (i) a payment by Melinta to Medicines of $165 million in cash (subject to a working capital adjustment) and the issuance to Medicines of a number of shares of Melinta common stock equal to $50 million, divided by 90% of the volume weighted average price for the trailing 10 trading day period ending 3 trading days prior to closing, (ii) a payment by Melinta to Medicines of $25 million following each of the twelve and eighteen month anniversaries of the closing date, (iii) payment by Melinta to Medicines of certain royalty payments, based on tiered net sales of the acquired products, and (iv) the assumption of certain liabilities.

Under the Deerfield commitment letter, the Deerfield Funds have also committed to purchase a number of shares of Melinta common stock, which we refer to as the Deerfield equity investment, equal to 9.985% of the number of shares of Melinta common stock outstanding immediately following the acquisition (inclusive of such shares) for a purchase price per share of $13.50, representing 90% of the closing price for Melinta common stock on November 28, 2017

- 

Vatera has committed to purchase 2,000,000 shares of Melinta common stock for an aggregate purchase price of $27 million or $13.50 per share, representing 90% of the closing price for the Melinta common stock on November 28, 2017.
http://ir.melinta.com/node/11406/html

REGN semanal

Rompiendo cuña ...

FARMAS

• En valor absoluto (pasta), Alexion
• En porcentaje, Omeros

RESTO

• En valor absoluto (pasta), Alphabet (Google)
• En porcentaje, Wirecard